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EDITORIAL
Renal cell loss through cell suicide
Kidneys from most patients with end-stage renal dis- regulatory proteins [1]. Representative families of apo-
ease (ESRD) are small. Indeed, a striking decrease in ptosis regulatory proteins include the cell death receptor
parenchymal cell number, associated with an increased (sensors for lethal stimuli), Bcl2 (comprising pro-apo-
amount of extracellular matrix, are features of chronic ptotic and anti-apoptotic members) and caspase (intra-
renal injury. However, only recently have researchers cellular effectors of apoptosis) families. Each of these
addressed the mechanisms responsible for renal cell loss. families comprises multiple, apparently redundant mem-
As parenchymal renal cells do not migrate to other or- bers. However, in some cases these proteins regulate cell
gans, cell death is considered to be the main process of death in a cell- and stimulus-specific manner. In this regard
renal cell demise. Apoptosis is an active form of cell it is necessary to characterize the apoptosis regulatory
death (cell suicide) that accounts for the clearance of proteins that determine renal cell fate during acute and
most of the 100,000 cells that die physiologically each chronic renal injury. In vitro studies suggest that some of
second in a human. Apoptosis has drawn the interest of these proteins, such as Fas and BclxL, do indeed modulate
nephrologists because it is regulated by extracellular and renal cell survival. Increased Fas expression sensitizes
intracellular proteins that are potential targets for a ther- tubular and mesangial cells to the lethality of FasL [4],
apeutic intervention [1]. while high levels of BclxL protect tubular epithelial cells
In this issue of Kidney International, Ying, Wang, and from a lethal environment [5]. The study by Ying, Wang,
Sanders describe an increased rate of glomerular and and Sanders is one of a flurry of papers describing changes
tubular cell apoptosis in an experimental model of one of in the expression of apoptotic regulatory proteins during
the most common causes of ESRD, that is, hypertensive the course of renal injury [2, 4–7]. These data identify
nephrosclerosis [2]. Increased rates of apoptosis are also potential targets for a therapeutic intervention and pro-
found in human and experimental renal diseases charac- vide a framework for the design of functional studies that
terized by parenchymal renal cell loss, such as acute directly address the role of specific apoptosis regulatory
renal failure and chronic progressive nephropathies. An proteins in the progression of renal failure.
abnormally high rate of parenchymal cell apoptosis in In Dahl/Rapp salt-sensitive rats fed a high NaCl diet
renal injury may have different, even contradictory con- for 21 days the renal expression of the pro-apoptotic pro-
sequences. First, apoptosis can be a compensatory re- teins Fas, Bax and BclxS was increased [2], although the
sponse to increased cell proliferation, as exemplified by cells expressing these proteins were not identified. This
the regression of glomerular hypercellularity in experi- pattern of high expression of pro-apoptotic proteins is
mental mesangial glomerulonephritis [3]. Indeed, Ying, reminiscent of that described in other renal and extrarenal
Wang, and Sanders also noted an increased rate of cell pathologies characterized by an increased rate of apopto-
proliferation [2]. However, the overall decrement in cell sis. Increased tubular expression of Bax was observed in
number as evidenced by tubular atrophy and glomerular nephrotoxic acute renal failure, although in this murine
sclerosis argues against this possibility in their model. model BclxS was not detected in the kidney [5]. Increased
Second, apoptosis could be contributing to the progres- tubular Fas was noted in two models of murine chronic
sion of chronic renal injury through cell loss and, third, renal failure [6]. These data suggest that some molecular
apoptosis could be an epiphenomenon that is not con- mechanisms for apoptosis are common to renal injury
tributing to the progression of injury and leads to the of different origins. One striking result is that a high
loss of otherwise damaged cells. To discriminate between NaCl dietary intake modulates the expression of the anti-
these two latter possibilities, functional studies aimed at apoptotic protein BclxL in both Dahl/Rapp salt-sensitive
specifically inhibiting apoptosis are needed. rats and control rats [2]. This finding merits further explo-
The susceptibility of a given cell to apoptosis is regu- ration, as dietary salt content is known to modulate sus-
lated both by the extracellular microenvironment and ceptibility to nephrotoxic injury [8]. As cells expressing
by the expression and activity of intracellular apoptosis BclxL were not identified, we cannot draw conclusions
about the ability of BclxL to prevent cell death in this
model. It should be emphasized, however, that a highKey words: apoptosis, end-stage renal disease, hypertensive nephro-
sclerosis. expression of pro-apoptotic Bcl2-family members, such
as Bax and BclxS, negates the protective effect of BclxL.Ó 2000 by the International Society of Nephrology
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renal injury. Inhibition of tubular epithelial cell apoptosis
by either the administration of survival factors or inhibi-
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